DU7-16705-18960
2 vaccinations
5 coded responses
11 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 280 / NC
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2020-12-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fever · Chills, Fatigue or tirednessAdult check-in
- 2020-12-27
- 2020-12-30
- 2021-01-06
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-01-27
Survey response — day 14, dose 2MedDRA: Chills, Fatigue, Pain — Feeling: FairFree text: Persistent fatigue, intermittent chills and bodyachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-03
-
2021-02-17
Survey response — day 35, dose 2MedDRA: Fatigue — Feeling: FairFree text: Intermittent fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Survey response — 3 months, dose 2MedDRA: Dyspnoea exertional, Exercise tolerance decreased — Feeling: GoodFree text: Since vaccination I have noticed a considerable decrease in exercise tolerance and shortness of breath upon exercise that was not present prior to vaccination. This was notable within 2-3 weeks of second dose when I first attempted to exercise.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-14
Survey response — 6 months, dose 2MedDRA: Arthralgia, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: multiple joint pains, mostly in the hands; also moderate to severe carpal tunnel syndromeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2022-01-15
Survey response — 12 months, dose 2MedDRA: Arthralgia, Grip strength decreased, Pain in extremity — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Following a few weeks after my second vaccine, I have had worsening joint pain in my hands, with significant weakness of my grip strength due to avoidance of grip (for instance it is very painful to write with pen/pencil due to right thumb pain)MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech |
Free text
Release 2 — day 14, dose 2
Symptoms: Persistent fatigue, intermittent chills and bodyaches
Release 4 — day 35, dose 2
Symptoms: Intermittent fatigue
Release 7 — 3 months, dose 2
Symptoms: Since vaccination I have noticed a considerable decrease in exercise tolerance and shortness of breath upon exercise that was not present prior to vaccination. This was notable within 2-3 weeks of second dose when I first attempted to exercise.
Release 9 — 6 months, dose 2
Symptoms: multiple joint pains, mostly in the hands; also moderate to severe carpal tunnel syndrome
Release 10 — 12 months, dose 2
Symptoms: Following a few weeks after my second vaccine, I have had worsening joint pain in my hands, with significant weakness of my grip strength due to avoidance of grip (for instance it is very painful to write with pen/pencil due to right thumb pain)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Dyspnoea exertional | ✓ | ✓ | ✓ |
| SD | Exercise tolerance decreased | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Grip strength decreased | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release